Biopsy Devices Market Size to Reach USD 3.69 Billion in 2028, Noted Reports and Data

Rising prevalence of cancer and increasing initiatives by governments and healthcare organizations to raise cancer awareness are predicted to fuel market growth

The global biopsy devices market size is expected to reach USD 3.69 billion by 2028 at a CAGR of 7.1%, according to the latest report by Reports and Data. Robust market growth can be primarily attributed to rising prevalence of chronic and infectious diseases worldwide, rising burden of life-threatening diseases such as cancer, increasing initiatives undertaken by governments and healthcare organizations to spread cancer awareness, and increasing number of biopsy procedures. The global biopsy devices market is expected to gain further momentum during the forecast period due to increasing demand for minimally invasive surgical procedures, rising awareness about early cancer diagnosis and treatment, rapidly growing patient pool, and emergence of advanced imaging technologies such as Computed Tomography (CT) and Magnetic Resonance Imaging (MRI).  

Biopsy is a medical test performed to remove tissue from the affected body part or organ to analyze the cause of a particular disease. Generally, the process involves removal of the tissue by inserting a needle into the body. A biopsy uses highly advanced imaging techniques such MRI, CT, ultrasound, and x-ray, and is generally performed to diagnose cancers, peptic ulcers, liver inflammation, kidney disorders, and various infections. Punch biopsy, needle biopsy, endoscopic biopsy, fine needle aspiration, and excisional and incisional biopsies are various biopsy procedures that are minimally invasive. Rising adoption of technologically enhanced biopsy procedures, such as stereotactic-guided biopsies, vacuum-assisted biopsies, ultrasound-guided biopsies, and 3D optical biopsies, and their advantages including smaller incisions, lesser pain and scarring, faster recovery, and higher cost-effectiveness are expected to further drive the global biopsy devices market growth in recent years.

Access Free sample PDF Copy of the Report @

Key Highlights of the Report:

  • Based on the product type, the global biopsy devices market is segmented into needle-based biopsy instruments, manual and robotic biopsy guidance systems, biopsy forceps, procedure trays, localization wires, and others.
  • Among the aforementioned segments, the needle-based biopsy instruments segment dominates in terms of revenue, owing to several favorable factors. Increasing use of needle-based biopsy instruments to diagnose breast, lung, and kidney cancers, growing demand for minimally invasive surgical procedures, and technological advancements in these products are pivotal factors expected to stimulate the growth of this segment.
  • Among key market regions, the North America biopsy devices market is the leading regional market and is expected to record highest revenue growth rate over the forecast period. Rising prevalence of life-threatening diseases such as cancer, growing adoption of advanced biopsy procedures such as vacuum-assisted biopsy systems, increasing need for early cancer diagnosis, and presence of leading-edge healthcare infrastructure in North America are primary factors driving the regional market growth.
  • Top companies operating in the global biopsy devices market are Medtronic Plc, Argon Medical Devices, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Boston Scientific Corporation, Fujifilm Holdings Corp., Cardinal Health, Inc., Danaher Corporation (Leica Microsystem), Hologic, Inc., Devicor Medical Products, Inc., Cook Medical, Inc., Olympus Corporation, INRAD, Inc., and C. R. Bard, Inc..
  • In January 2021, researchers at the Corpuscular Physics Institute developed a new real-time guided biopsy device for use in cancer diagnosis and treatment. The new device is expected to make the treatment process highly cost-effective and personalized.

Buy now your Exclusive copy of Report @

For the purpose of this report, the global biopsy devices market is segmented based on product type, imaging technique, application, end-use, and region:

By Product Type (Revenue, USD Billion; 2018-2028)

  • Needle-based Biopsy Instruments
    • Core Biopsy Devices
      • Core Biopsy Guns
      • Core Biopsy Needles
    • Vacuum-assisted Biopsy Devices
      • Vacuum-assisted Biopsy Systems
      • Vacuum-assisted Biopsy Needles
    • Aspiration Biopsy Needles
  • Manual and Robotic Biopsy Guidance Systems
  • Biopsy Forceps
  • Procedure Trays
  • Localization Wires
  • Others (brushes, punches, curettes, etc.)

By Imaging Technique (Revenue, USD Billion; 2018-2028)

  • Ultrasound-guided Biopsy
  • Stereotactic-guided Biopsy
  • MRI-guided Biopsy
  • CT Scan
  • Others

By Application (Revenue, USD Billion; 2018-2028)

  • Lung biopsy
  • Liver biopsy
  • Kidney biopsy
  • Gastroenterological biopsy
  • Gynecological biopsy
  • Breast biopsy 
  • Prostate biopsy
  • Others 

By End-use (Revenue, USD Billion; 2018-2028)

  • Hospitals
  • Diagnostic and Imaging Centers
  • Academic & Research Institutes
  • Others

Request for Custom Research @

By Region (Revenue, USD Billion; 2018-2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Rest of the Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Rest of the Middle East & Africa

Explore Reports and Data's Prime Analysis of the global Pharmaceutical & Healthcare Industry:

Gastrointestinal Devices Market By Devices Type (GI Videoscopes, Biopsy Devices, Capsule Endoscopy, ERCP Devices), By Sales Channel (Online, Medical Stores), By End-Users (Hospitals, Ambulatory Surgery Centers) And Segment Forecasts, 2016-2027

Breast Biopsy Device Market Analysis, by Type (Needle Biopsy, Open Surgical Biopsy) by Product (Needles, Tables, Markers) by Guidance type (Mammography, Ultrasound, MRI, CT Scan) by End use (Hospital, Diagnostic Clinics, Others), Forecast to 2017–2027

Mammography Market By Type (Screening, Diagnostic), By Sales Channel (Online, Stores), By Applications (Breast Imaging, Stereotactic Biopsy), By Technology (Analog, Breast Tomosynthesis), By End-Users (Hospitals, ASC) And Segment Forecasts, 2016-2027

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:

John W

Head of Business Development

Reports and Data | Web:

Direct Line: +1-212-710-1370


Read Full Press Release:

Back to news